+ All Categories
Home > Health & Medicine > The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Date post: 07-May-2015
Category:
Upload: ahmed-bahnassy
View: 1,090 times
Download: 1 times
Share this document with a friend
Description:
Step by step evaluation by HRCT of pediatric ILD.
46
The road to HRCT evaluation of Dr/Ahmed Bahnassy Consultant Radiologist Riyadh Military Hospital
Transcript
Page 1: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

The road to HRCT evaluation of

Dr/Ahmed Bahnassy

Consultant Radiologist

Riyadh Military Hospital

Page 2: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Does chILD differ from adILD?1. Differences in the immune system

responces, cytokine and growth factors

2. Histologic classification differs significantly

3. Specific types presented at children not adults

4. Rarer and less stereotyped than adult ILD

5. More difficult to treat than adults.

Page 3: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

DIP Desquamative interstitial pneumonitis

CIP Chronic pneumonitis of infancy

NSIP Non-specific interstitial pneumonitis

FB/LIP Follicular bronchiolitis /lymphoid

Interstitial Pneumonia

OP Organizing pneumonia (old BOOP)

PIG Pulmonary interstitial glycogenosis

NEHI Neuroendocrine cell hyperplasia of infancy

* UIP: Usual interstitial pneuminitis is rare in children.

Examples of common terms of chILD

Page 4: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Diagnostic journey of chILD?• First round investigations:

1. Imaging (HRCT)

2. Lung functions (DLCO)

3. Oxygen saturation (rest /exercise)

4. Blood tests (CBC, ESR, Immune, Serology and PCR, RAST, ACE, HIV)

5. Resp secretions cultures/PCR

6. Sweat chloride test.

7. pH study/Contrast swallow

8. ECG and ECHO

9. Ciliary Brush Biopsy

10. Urine for CMV PCR

Page 5: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

• Second round investigations:

1. Upper GI study for ? H type fistula

2. Bronchoscopy and BAL for cytology (LCH, iron laden macrophages, PAP) and cultures

3. Videofluroscopy for aspiration evidence

4. Cardiac Cath

5. Detailed lymphocyte function tests

6. TB –Elispot test

• Third round investigations:

1. Lung biopsy

(Transbronchial,percutaneous, thoracoscopic, open lung) CT guided from affected patch and unaffected patch.

• Special stains (eg. Bompesin or PAS)

• Immunoblotting for sufactant proteins at lung biopsy

• Electron microscopy study of biopsy

• DNA for mutations in SPB, SPC and ABCA3

Page 6: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

HRCT in children

parameters

SPL

Page 7: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Glossary ofTerms of HRCT

Same terminology for both adults and pediatrics

Page 8: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

beaded septum sign

This sign consists of irregularand nodular thickening of interlobularsepta reminiscent of a row of beads

Page 9: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

bronchiectasis

Bronchiectasis is irreversiblelocalized or diffuse bronchial dilatation,usually resulting from chronic infection,proximal airway obstruction, orcongenital bronchial abnormality

Page 10: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

signet ring sign

This finding is composed ofa ring-shaped opacity representing a dilatedbronchus in cross section and asmaller adjacent opacity representingits pulmonary artery, with the combinationresembling a signet (or pearl) ring.

Page 11: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

bronchiolectasis

Bronchiolectasis is definedas dilatation of bronchioles. It is causedby inflammatory airways disease (potentiallyreversible) or, more frequently,fibrosis

Page 12: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

bronchocele

A bronchocele is bronchialdilatation due to retained secretions(mucoid impaction) usually caused byproximal obstruction, either congenital(eg, bronchial atresia) or acquired (eg,obstructing cancer)

Page 13: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

bronchocentric

This descriptor is applied todisease that is conspicuously centeredon macroscopic bronchovascular bundlesExamples of diseases witha bronchocentric distribution includesarcoidosis , Kaposi sarcoma ,and organizing pneumonia .

Page 14: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

broncholith

A broncholith, a calcifiedperibronchial lymph node that erodesinto an adjacent bronchus, is most oftenthe consequence of Histoplasma or tuberculousinfection.

Page 15: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

cavity

A cavity is a gas-filled space, seen as a lucency or low-attenuation area, within pulmonary consolidation, a mass, or a nodule

Page 16: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

crazy-paving pattern

This pattern appears asthickened interlobular septa and intralobularlines superimposed on abackground of ground-glass opacity , resembling irregularly shaped pavingstones.

Page 17: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

cyst

A cyst is any round circumscribedspace that is surrounded by anepithelial or fibrous wall of variablethickness

Page 18: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

consolidation

Consolidation refers to anexudate or other product of disease thatreplaces alveolar air, rendering the lungsolid (as in infective pneumonia).

Page 19: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

ground-glass opacity

Area of hazy increased lungopacity, usually extensive, within whichmargins of pulmonary vessels may beindistinct. On CT scans, it appears ashazy increased opacity of lung, withpreservation of bronchial and vascularmargins

Page 20: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

halo sign

The halo sign is a CT finding of ground-glass opacity surrounding a nodule or mass..It refers to severe pulmonary infection..first

described with invasive aspergillosis in leukemic patients .

Page 21: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

reversed halo sign

The reversed halo sign is afocal rounded area of ground-glassopacity surrounded by a more or lesscomplete ring of consolidation .A rare sign, it was initially reported tobe specific for cryptogenic organizingpneumonia but was subsequentlydescribed in patients with paracoccidioidomycosis

Page 22: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

honeycombing

Honeycombing representsdestroyed and fibrotic lung tissue containingnumerous cystic airspaces withthick fibrous walls, representing the latestage of various lung diseases, withcomplete loss of acinar architecture.The cysts range in size from a few millimetersto several centimeters in diameter, andhave variable wall thickness.

Page 23: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

parenchymal band

It is a linear opacity, usually1–3 mm thick and up to 5 cm long thatusually extends to the visceral pleura(which is often thickened and may beretracted at the site of contact).It reflects pleuroparenchymal fibrosisand is usually associated with distortionof the lung architecture.

Page 24: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

mycetoma

A mycetoma is a discretemass of intertwined hyphae, usually ofan Aspergillus species, matted togetherby mucus, fibrin, and cellular debris colonizinga cavity, usually from prior fibrocavitarydisease (eg, tuberculosis orsarcoidosis)

Page 25: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

tree-in-bud pattern

The tree-in-bud pattern representscentrilobular branching structuresthat resemble a budding tree. Thepattern reflects a spectrum of endo- andperibronchiolar disorders, including mucoidimpaction, inflammation, and/or fibrosis

Page 26: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Nice summary From Dr/Richard Webb

Page 27: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Secondary Pulmonary Lobule disease patterns

Same usage for both adults and pediatrics

with different significance

Page 28: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

The “Unit” of the lung

The secondary pulmonary lobule is a fundamental unit oflung structure, and it reproduces the lung in miniature.Airways, pulmonary arteries, veins, lymphatics, and thelung interstitium are all represented at the level of thesecondary lobule.

Page 29: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Anatomy of SPL

Page 30: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

I-Perilobular pathology

Page 31: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Lymphangitic carcinomatosis

Page 32: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Sarcoidosis

Page 33: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Idipathic pulmonary fibrosis(rare in children)

• Typical HRCT findings in adults.

Page 34: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

II-Centrilobular pathology.

Page 35: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Hypersensitivity pneumonitis

Page 36: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Cellular bronchiolitis

Page 37: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Tree-in-budin patients with a centrilobulardistribution of nodules, if the tree-inbudsign can be recognized the differentialdiagnosis is limited: Endobronchial spread of tuberculosis or nontuberculous mycobacteria Bronchopneumonia,infectious bronchiolitis Cystic fibrosis , bronchiectasis of anycause diffuse panbronchiolitisasthma or allergic bronchopulmonaryaspergillosis , constrictivebronchiolitis , follicular bronchiolitis,bronchioloalveolar carcinoma, and

intravascular metastases.

Page 38: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Centrilobular emphysema

Centrilobular (centriacinar) emphysemais characterized histologicallyby areas of lung destruction occurringin relation to centriacinarbronchioles and, therefore, is locatedin the center of the secondary lobuleor surrounding the centrilobular region

Page 39: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

III-Panlobular pathology

Page 40: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Lobular Process

Pneumonia

Hypersensitivity pneumonitis

Page 41: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Headcheese sign in hypersensitivity pneumonitis

The headcheese sign is indicative of

mixed infiltrative and obstructive disease, usually associated with bronchiolitis

The most common causes of this patternare hypersensitivity pneumonitis, desquamativeinterstitial pneumonia or respiratorybronchiolitis–interstitial lung disease,sarcoidosis, and atypical infectionswith associated bronchiolitis, such as occurswith M pneumoniae.

Page 42: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Consider the distribution of the pathology

Same principle for both adults and pediatrics.for DD

Page 43: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Cranio-caudal axis

Apical

middle Basal

Page 44: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Transverse axis

CentralPeripheral

Or both

Page 45: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Antero-posterior axis

Anterior Posterior

Or both

Page 46: The road to HRCT evaluation of pediatric diffuse lung diseases .part 1

Recommended